Johnson & Johnson ($JNJ) Insider Trading & Smart Money Activity
Johnson & Johnson ($JNJ) has 1 insider trade, 10 congress trades, 51 13F position changes and 9 analyst ratings on file. In the last 12 months on the open market, no insider bought and 1 insider sold ($2.41M), net -$2.41M.
- Insider buyers (12 mo)
- 0
- Insider sellers (12 mo)
- 1
- Net insider $ (12 mo)
- -$2.41M
- Congress trades (12 mo)
- 9
- 13F moves on file
- 51
- Analyst ratings on file
- 9
JNJ insider buying and selling by quarter
| Quarter | Insider buys | Insider sales | Congress buys / sales | 13F added / cut |
|---|---|---|---|---|
| Q1 2026 | 0 | 0 | 2 / 0 | 0 / 0 |
| Q2 2026 | 0 | 1 · $2.41M | 1 / 2 | 16 / 9 |
| Q3 2026 | 0 | 0 | 1 / 3 | 0 / 0 |
| Q4 2026 | 0 | 0 | 0 / 0 | 12 / 14 |
Insider buys and sales count open-market trades only (Form 4 codes P and S). Grants, option exercises and tax withholding are left out.
All JNJ insider, congress, 13F and analyst activity
| Date | Source | Who | Action | Shares | Value / amount | ΔOwn | 1W | 1M | 6M | Filing | Story |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Analyst | Wells Fargo | Reiterates to Overweight | PT $287 | Read | |||||||
| 13F | SteelPeak Wealth | Reduced | -54K sh | $9.72M | — | ||||||
| 13F | Saratoga Research & Investment Management | Reduced | -13.33K sh | $70.19M | — | ||||||
| 13F | PineStone Asset Management | Reduced | -97.10K sh | $433.31M | — | ||||||
| 13F | DiNuzzo Private Wealth | Added | +395 sh | $217.80K | — | ||||||
| 13F | ARS Wealth Advisors Group | Reduced | -1.52K sh | $31.66M | — | ||||||
| Analyst | Morgan Stanley | Reiterates to Overweight | PT $292 | Read | |||||||
| 13F | Zwj Investment Counsel | Added | +6.67K sh | $61.28M | Read | ||||||
| 13F | V-Square Quantitative Management | Added | +3.35K sh | $15.30M | — | ||||||
| 13F | Ninety One UK | Reduced | -285.33K sh | $1.72B | Read | ||||||
| 13F | Ninety One North America | Reduced | -15.11K sh | $71.68M | — | ||||||
| 13F | Mirae Asset Securities (Usa) | Added | +25.02K sh | $13.26M | — | ||||||
| 13F | HCR Wealth Advisors | Added | +2.68K sh | $4.09M | — | ||||||
| 13F | Guyasuta Investment Advisors | Reduced | -3.19K sh | $26.34M | — | ||||||
| 13F | Gleason Group | Reduced | -766 sh | $1.55M | — | ||||||
| 13F | Fort Washington Investment Advisors | Reduced | -539.92K sh | $107.11M | Read | ||||||
| 13F | Fjarde Ap-Fonden /Fourth Swedish National Pension Fund | Reduced | -151.53K sh | $292.57M | Read | ||||||
| 13F | First Merchants | Reduced | -3.10K sh | $12.29M | — | ||||||
| 13F | Cohen Klingenstein | Reduced | -3.88K sh | $32.86M | — | ||||||
| 13F | Auto-Owners Insurance | Reduced | -77.28K sh | $60.27M | — | ||||||
| 13F | Assenagon Asset Management S.A. | Added | +1.05M sh | $791.76M | Read | ||||||
| Analyst | Wells Fargo | Reiterates to Overweight | PT $275 | Read | |||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $280 | Read | |||||||
| Analyst | Leerink Partners | Reiterates to Outperform | PT $272 | Read | |||||||
| 13F | Thurston, Springer, Miller, Herd & Titak | Reduced | -6.07K sh | $591.94K | — | ||||||
| 13F | Patriot Financial Group Insurance Agency | Added | +13.41K sh | $5.91M | — | ||||||
| 13F | Moody Lynn Lieberson & Walker | Added | +3.61K sh | $36.60M | — | ||||||
| 13F | Mather Group | Added | +14.25K sh | $21.52M | — | ||||||
| 13F | IFM Investors | Added | +19.80K sh | $153.48M | — | ||||||
| 13F | First Citizens Bank & Trust | Added | +22.14K sh | $14.02M | Read | ||||||
| Analyst | Guggenheim | Reiterates to Buy | PT $287 | -1.8% | — | ||||||
| Analyst | RBC Capital | Reiterates to Outperform | PT $290 | -2.4% | — | ||||||
| Analyst | Citigroup | Reiterates to Buy | PT $303 | +4.3% | — | ||||||
| Congress | Lloyd Doggett | Purchase | $1,001 - $15,000 | -0.7% | -4.7% | Read | |||||
| Congress | Thomas H. Kean Jr. | Sale | $1,001 - $15,000 | +4.8% | +2.3% | — | |||||
| Congress | John Boozman | Sale | $1,001 - $15,000 | -0.1% | +1.3% | — | |||||
| Congress | Richard McCormick | Sale | $1,001 - $15,000 | +0.5% | +4.4% | — | |||||
| Congress | Thomas H. Kean Jr. | Sale | $1,001 - $15,000 | +0.3% | +2.7% | — | |||||
| Analyst | Guggenheim | Reiterates to buy | PT $270 | +1.8% | +4.4% | Read | |||||
| Insider | Kathryn WengelEVP, Chief TO and Risk Officer | Sell (Open-market sale) | 10K sh | $2.41M | -4.2% | +8.2% | — | ||||
| Congress | Lloyd Doggett | Purchase | $1,001 - $15,000 | -0.8% | +9.3% | — | |||||
| Congress | Thomas H. Kean Jr. | Sale | $1,001 - $15,000 | +6.3% | +18.0% | — | |||||
| Congress | Alan Armstrong | Purchase | $1,001 - $15,000 | -0.6% | -6.2% | +13.4% | — | ||||
| Congress | Alan Armstrong | Purchase | $15,001 - $50,000 | +0.2% | -6.3% | +14.0% | — | ||||
| Congress | Tommy Tuberville | Sale | $15,001 - $50,000 | — |
Showing 45 of 71 filings (the latest 13F moves are capped at 25; see the institutions below).
1W / 1M / 6M = how JNJ moved from the trade or filing date.
Insider trading in JNJ: who is buying and selling
| Insider | Role | Trades | Open-market net | Shares held | Last trade |
|---|---|---|---|---|---|
| Kathryn Wengel | EVP, Chief TO and Risk Officer | 1 | -$2.41M | Jun 11, 2026 |
Members of Congress trading JNJ
Institutions moving JNJ (13F)
- Pinestone Asset Management2
- Ninety One UK2
- Fort Washington Investment Advisors2
- Ifm Investors2
- SteelPeak Wealth1
- Saratoga Research & Investment Management1
- DiNuzzo Private Wealth1
- ARS Wealth Advisors Group1
- Zwj Investment Counsel1
- V-Square Quantitative Management1
- Ninety One North America1
- Mirae Asset Securities (Usa)1
Analyst ratings on JNJ
| Date | Firm | Action | Rating | Price target | 1W | 1M | 6M | Story |
|---|---|---|---|---|---|---|---|---|
| Wells Fargo | Reiterates | Overweight | $275 → $287 | Read | ||||
| Morgan Stanley | Reiterates | Overweight | $294 → $292 | Read | ||||
| Wells Fargo | Reiterates | Overweight | $282 → $275 | Read | ||||
| RBC Capital | Reiterates | Outperform | $290 → $280 | Read | ||||
| Leerink Partners | Reiterates | Outperform | $276 → $272 | Read | ||||
| Guggenheim | Reiterates | Buy | $287 | -1.8% | — | |||
| RBC Capital | Reiterates | Outperform | $287 → $290 | -2.4% | — | |||
| Citigroup | Reiterates | Buy | $298 → $303 | +4.3% | — | |||
| Guggenheim | Reiterates | buy | $270 | +1.8% | +4.4% | Read |
Frequently asked questions
Are JNJ insiders buying or selling?
Over the last 12 months 0 insiders made 0 open-market purchases worth $0 and 1 insider made 1 open-market sale worth $2.41M, a net -$2.41M.
What is the latest insider trade in JNJ?
Kathryn Wengel, EVP, Chief TO and Risk Officer filed a sell (open-market sale) of 10K sh worth $2.41M on Jun 11, 2026.
Which members of Congress traded JNJ?
10 disclosed trades by Thomas H. Kean Jr., Lloyd Doggett, Alan Armstrong, John Boozman and Richard McCormick. The latest was on Sep 8, 2026.
Which institutions changed their JNJ positions?
Recent 13F filers moving the stock include Pinestone Asset Management, Ninety One UK, Fort Washington Investment Advisors, Ifm Investors and SteelPeak Wealth.
Other drug manufacturers - general stocks
Data comes from public SEC Form 4 and 13F filings and STOCK Act disclosures. Dates are the trade or filing date reported. This page is for research only and is not investment advice.
Get a text when insiders, Congress or big funds trade a stock.
Free. Reply STOP anytime.